Authors
Erin Godecke, Edith Cowan UniversityFollow
Tapan Rai
Dominique A Cadilhac
Elizabeth ArmstrongFollow
Sandy Middleton
Natalie CicconeFollow
Anne Whitworth
Miranda L Rose
Audrey Holland
Fiona Ellery
Graeme J Hankey
Julie Bernhardt
Document Type
Journal Article
Publication Title
International Journal of Stroke
ISSN
1747-4949
Volume
13
Issue
8
First Page
863
Last Page
880
PubMed ID
30270762
Publisher
Sage Publications Ltd
Place of Publication
United Kingdom
School
School of Medical and Health Sciences
RAS ID
27660
Grant Number
NHMRC Number: 1044973
Grant Link
http://purl.org/au-research/grants/nhmrc/1044973
Abstract
Background Limited evidence exists to support very early intensive aphasia rehabilitation after stroke. VERSE is a PROBE trial designed to determine whether two types of intensive aphasia therapy, beginning within 14 days of acute stroke, provide greater therapeutic and cost-effectiveness than usual care. Objective To publish the detailed statistical analysis plan for the VERSE trial prior to unblinding. This statistical analysis plan was based on the published and registered VERSE trial protocol and was developed by the blinded steering committee and management team, led by the trial statistician. This plan was developed using outcome measures and trial data collection forms. Results The VERSE statistical analysis plan is consistent with reporting standards for clinical trials and provides for clear and open reporting. Conclusions Publication of a statistical analysis plan serves to reduce potential trial reporting bias and outlines transparent pre-specified analyses. Australian New Zealand Clinical Trials Registry (ANZCTR) Registration number: ACTRN12613000776707; Universal Trial Number (UTN) is U1111-1145-4130.
DOI
10.1177/1747493018790055
Comments
This is an Author's Accepted Manuscript of: Godecke, E., Rai, T., Cadilhac, D. A., Armstrong, E., Middleton, S., Ciccone, N., ... & Hankey, G. J. (2018). Statistical analysis plan (SAP) for the Very Early Rehabilitation in Speech (VERSE) after stroke trial: an international 3-arm clinical trial to determine the effectiveness of early, intensive, prescribed, direct aphasia therapy. International Journal of Stroke, 13(8), 863-880. Available here.